News
Revealing burden of disease
LEO Pharma has conducted the first truly large scale international study informed by both qualitative and quantitative data to investigate the impact of psoriasis. The findings reveal that feelings of restriction, isolation, stigmatisation and anxiety are associated with a high impact on patients’ lives - and are more important than diagnosed symptom severity.